Page last updated: 2024-08-21

benzoxazoles and gallium ga 68 dotatate

benzoxazoles has been researched along with gallium ga 68 dotatate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergsland, EK; Chamberlain, CE; Donner, DB; Ducker, GS; German, MS; Hann, B; Kim, GE; Lee, D; Nakakura, EK; Regan, M; Shokat, KM; VanBrocklin, H; Venook, AP; Wang, J; Wang, Y; Warren, RS; Yang, K	1

Other Studies

1 other study(ies) available for benzoxazoles and gallium ga 68 dotatate

Article	Year
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. Molecular cancer therapeutics, 2018, Volume: 17, Issue:12 Topics: Animals; Benzoxazoles; Cell Line, Tumor; Drug Resistance, Neoplasm; Everolimus; Humans; Mice, Nude; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2018

Article

Year

A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors.

Molecular cancer therapeutics, 2018, Volume: 17, Issue:12

Topics: Animals; Benzoxazoles; Cell Line, Tumor; Drug Resistance, Neoplasm; Everolimus; Humans; Mice, Nude; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018